Abstract
Cells often respond to viral infection by activating a cellular suicide process, limiting viral replicative potential and hence minimising the spread of the infection. This cellular self-destruction, termed apoptosis, occurs in a tightly regulated, morphologically and biochemically defined manner. To counter this host response to infection, some viruses have evolved molecular strategies to evade apoptosis by encoding proteins that inhibit components of the hosts apoptotic machinery. The first identified member of the p35 family, encoded by an insect virus genome, was cloned by virtue of its ability to inhibit insect cell death induced by viral infection. Many insect viruses carry p35 genes and numerous studies have indicated that p35 proteins can suppress a wide variety of cell death stimuli in cells of evolutionarily divergent organisms. A second member of the p35 family, p49, has also recently been cloned and characterised. Like p35, p49 was originally isolated as an inhibitor of infection mediated insect cell death but can also suppress other apoptotic stimuli. Members of the p35 family suppress apoptosis by inhibiting caspases, a family of cysteine proteases that constitute the effector arm of cell death pathways, through a substrate-inhibitor mechanism. This article reviews the anti-apoptotic capacities of members of the p35 family and the mechanism of action underlying their pro-survival activity. Insights into the molecular regulation of apoptosis gained through experimental approaches exploiting p35 family members are also discussed.
Keywords: apoptosis, baculovirus, caspases, caspase independent
Current Genomics
Title: The p35 Family of Apoptosis Inhibitors
Volume: 5 Issue: 3
Author(s): A. M. Jabbour and C. J. Hawkins
Affiliation:
Keywords: apoptosis, baculovirus, caspases, caspase independent
Abstract: Cells often respond to viral infection by activating a cellular suicide process, limiting viral replicative potential and hence minimising the spread of the infection. This cellular self-destruction, termed apoptosis, occurs in a tightly regulated, morphologically and biochemically defined manner. To counter this host response to infection, some viruses have evolved molecular strategies to evade apoptosis by encoding proteins that inhibit components of the hosts apoptotic machinery. The first identified member of the p35 family, encoded by an insect virus genome, was cloned by virtue of its ability to inhibit insect cell death induced by viral infection. Many insect viruses carry p35 genes and numerous studies have indicated that p35 proteins can suppress a wide variety of cell death stimuli in cells of evolutionarily divergent organisms. A second member of the p35 family, p49, has also recently been cloned and characterised. Like p35, p49 was originally isolated as an inhibitor of infection mediated insect cell death but can also suppress other apoptotic stimuli. Members of the p35 family suppress apoptosis by inhibiting caspases, a family of cysteine proteases that constitute the effector arm of cell death pathways, through a substrate-inhibitor mechanism. This article reviews the anti-apoptotic capacities of members of the p35 family and the mechanism of action underlying their pro-survival activity. Insights into the molecular regulation of apoptosis gained through experimental approaches exploiting p35 family members are also discussed.
Export Options
About this article
Cite this article as:
Jabbour M. A. and Hawkins J. C., The p35 Family of Apoptosis Inhibitors, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349417
DOI https://dx.doi.org/10.2174/1389202043349417 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Integrating Machine Learning with Genome Science: Pioneering Developments and Future Directions
Integrating machine learning (ML) with genome science is driving transformative advancements in fields such as genomics, personalized medicine, and drug discovery. Genomic data is vast and complex, making traditional analysis methods inadequate for uncovering deep insights. Machine learning, particularly deep learning models like convolutional neural networks (CNNs) and recurrent neural ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cholesterol and Alzheimers Disease: Clinical and Experimental Models Suggest Interactions of Different Genetic, Dietary and Environmental Risk Factors
Current Drug Targets Anti-Inflammatory Agents in Ageing and Age-Associated Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry An Efficient Synthesis of 4-Aryl-1,4-dihydropyridines Via VB1 Catalyzed Hantzsch Reaction
Letters in Organic Chemistry Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation
Current Molecular Medicine Therapeutic Window, a Critical Developmental Stage for Stem Cell Therapies
Current Stem Cell Research & Therapy Adolescents’ Rights: Better for Promoting Individual Rights or Public Health?
Adolescent Psychiatry ADAM9 as a Potential Target Molecule in Cancer
Current Pharmaceutical Design Emerging Molecular Targets for Treatment of Erectile Dysfunction: Vascular and Regenerative Therapies on the Horizon
Current Drug Targets The Long Way to Objectify Organ Damage Related to Cocaine Abuse: Oxidative Stress is the Main Culprit
Mini-Reviews in Organic Chemistry Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly
Current Pharmaceutical Design Neonatology in the United States: Where we are, and where we are Going
Current Pediatric Reviews Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research The State of the Problem of Achieving Extremely Low LDL Levels
Current Pharmaceutical Design Regressing Left Ventricular Hypertrophy: The Role of Telmisartan and Other ARBs
Current Hypertension Reviews Mechanism-Based Inhibitors from Phytomedicine: Risks of Hepatotoxicity and their Potential Hepatotoxic Substructures
Current Drug Metabolism New Approaches in the Diagnosis of Atherosclerosis and Treatment of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery The Shift in the “Paradigm” of the Pharmacology of Hypertension
Current Topics in Medicinal Chemistry Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases
Current Pharmaceutical Design Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study
Current Vascular Pharmacology